Perhaps due to the inter-relationships amongst alkaline phosphatase, cardiovascular disease, cognition and renal function, as well as the overlap between the CKD and cognition subgroup populations, we might expect to hear about eGFR changes at the same as we hear about MoCA score changes at CTAD early next month?
BDAZ